The short version of stability fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-06-05 and is reviewed periodically as new material appears.
Purity and identity are usually assessed with reverse-phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry. RP-HPLC separates components by hydrophobicity and can estimate peptide purity. Mass spectrometry confirms molecular mass and helps detect truncations or modifications. Some laboratories also use amino acid analysis or nuclear magnetic resonance for structural verification. A certificate of analysis from a supplier may list these results, but independent verification is often recommended for critical work.
Regulatory status varies by country, and dihexa is not widely approved as a medicine. In many jurisdictions it is treated as a research chemical, which limits its legal sale, possession, and human use. Products marketed online may lack verified purity or identity, and labels can be inaccurate. Researchers typically source material from suppliers that provide analytical documentation and follow institutional safety rules. Open questions remain about long-term stability, metabolite formation, and human pharmacokinetics.
Most published work on dihexa consists of preclinical studies using cell cultures or rodents. Reports have described effects on synaptic connectivity and performance on cognitive tasks in some animal models. These findings are generally presented as preliminary and require independent replication. Study designs, doses, and outcome measures vary across experiments, which complicates direct comparison. No large controlled human trials have established efficacy or safety for any medical use. At present, the evidence base is limited.
Regulatory agencies have not approved dihexa as a prescription drug or supplement. In many countries it falls into a gray area when sold for laboratory research. Buyers may encounter products marketed for research use only, which are not intended for human consumption. Purity and identity can vary between suppliers and batches. Certificates of analysis and independent testing are often recommended for research materials. Documentation helps verify what a vial contains.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Typical lyophilized research form. |
| Solubility | Soluble in DMSO; limited in water | Depends on purity and salt form. |
| Storage temperature | -20 °C or lower | Desiccated and protected from light. |
| Analytical method | RP-HPLC and LC-MS | Common for purity and identity. |
| Regulatory status | Research chemical in many countries | Not widely approved as a medicine. |
In laboratory settings, dihexa is typically handled as a research chemical rather than a pharmaceutical product. Suppliers may provide it as a lyophilized powder or in solution, and purity is often stated as a percentage determined by chromatographic analysis. Because independent verification is uncommon, researchers generally rely on certificates of analysis, which may include high-performance liquid chromatography and mass spectrometry data. The absence of pharmacopeial monographs means that identity, purity, and impurity profiles can vary between batches and suppliers.
Storage recommendations for peptides and peptide-like compounds usually emphasize low temperatures, desiccation, and protection from light. A common practice is to keep dry powder at -20 °C or below and to prepare solutions shortly before use. Repeated freeze-thaw cycles may degrade the material, so aliquoting is often advised. Solubility depends on the solvent; aqueous solubility may be limited, and organic solvents such as dimethyl sulfoxide are sometimes used for stock solutions. Stability data specific to dihexa are sparse, so general peptide handling guidelines are often applied instead.
Analytical confirmation generally combines a separation method with a detection method. Reverse-phase high-performance liquid chromatography can assess purity, while mass spectrometry supports molecular identity. For research-grade material, a certificate of analysis may report a batch-specific purity value, but it does not guarantee biological activity or safety. Regulatory frameworks vary by country; many jurisdictions treat dihexa as a research chemical not intended for human consumption. Purchasers should verify local rules and supplier documentation. The absence of official standards makes independent testing and careful record-keeping important for laboratory work.
Identity and purity are usually assessed with reverse-phase high-performance liquid chromatography and mass spectrometry. These methods can separate related impurities and confirm molecular mass, but they do not by themselves establish biological activity. Certificate of analysis documents may report purity as a percentage by area, yet the exact meaning can vary between laboratories. Independent testing can check for residual solvents, counterions, or microbial contamination when relevant. For research use, matching analytical records to a specific lot helps trace experimental variability.
Dihexa occupies an uncertain regulatory space in many countries. It is not generally listed as an approved therapeutic, and some jurisdictions may treat it as a research chemical, a compounded substance, or an unapproved new drug depending on claims and distribution. Importation can be restricted, and suppliers may require documentation that the material is for laboratory research only. Quality and labeling vary, so buyers should request analytical data, verify lot numbers, and understand local rules. These factors make sourcing and compliance part of the practical context around dihexa.
The leading hypothesis for dihexa centers on hepatocyte growth factor (HGF) and its receptor, c-Met. In cell-based assays, dihexa has been reported to potentiate HGF-dependent signaling. That pathway influences cell growth, survival, and motility. Because c-Met signaling is widespread, the proposed mechanism is broad rather than specific to neurons. The exact binding site and stoichiometry remain areas of active investigation, and independent replication is limited. This uncertainty limits firm conclusions about how the compound acts in living organisms.
Animal studies have examined dihexa in models of cognitive impairment, synaptic plasticity, and memory. Some reports describe improved performance on maze or avoidance tasks after administration. These findings are preclinical and often involve small samples, varied routes, and differing formulations. Results in rodents do not establish effects in humans. The absence of published randomized controlled trials in people is a major gap in the evidence base. Observational reports and user accounts do not substitute for controlled clinical data.
Discussion in the literature often separates direct receptor activation from downstream growth-factor modulation. Dihexa is not simply an angiotensin receptor blocker or a classic nootropic drug. Its proposed action may depend on endogenous HGF levels, which vary by tissue and physiological state. Questions remain about brain penetration, metabolic stability, and active metabolites. Reviews note that mechanistic claims should be treated as hypotheses until supported by independent studies. That distinction is important when interpreting promotional claims or early laboratory findings.
Fresh parsley is 88% water, 6% carbohydrates, 3% protein, and 1% fat (table). In a reference amount of 100 g (3.5 oz), raw parsley supplies 36 calories and is a rich source (20% or more of the Daily Value, DV) of vitamin K, vitamin C, vitamin A, folate, and iron, with moderate content of other dietary minerals (table). Fresh parsley contains apigenin and myricetin.
=== Embedding === Tissues are embedded in a harder medium both as a support and to allow the cutting of thin tissue slices. In general, water must first be removed from tissues (dehydration) and replaced with a medium that either solidifies directly, or with an intermediary fluid (clearing) that is miscible with the embedding media.
On 26 February, Agüero's sisters Natalia Agüero and Celeste Severín gave an impact testimony, saying that they do not believe their sister is a murderer, and asked for her acquittal. Natalia Agüero highlighted Brenda's upbringing with their parents and the impact that their divorce had on her. She also told of their time in Buenos Aires and then back in Río Ceballos and how Brenda allegedly dedicated herself to her job. Celeste Severín said that her sister is a perejil (lit. parsley) which is Argentinian slang for "fool", and was allowed to hug Brenda before exiting the courtroom. On 10 March, the Homicides Division of Córdoba Police presented another report accusing Agüero of being the only person with an "active participation" in every case. The investigators highlighted that in the case of 1 May 2022 (baby G.H.), Agüero predicted that the baby would decompensate, even when the baby was healthy and without any complications. On 11 March, the prosecution presented a series of photographs taken from Agüero's cell phone. The court chose three of those for evaluation by psychologists and psychiatrists: one photo of babies in incubators, another picture of a vial of vitamin K, and a third picture that showed the hand of a baby with three red spots on it. Said evaluators found that the pictures relate closely to Agüero's psychopathic personality, especially under the lack of empathy shown to the families of the victims. On 15 April, Agüero began her final statement before the court, where she denied committing the murders.
Sources: en.wikipedia.org
Chevreul's scientific work covered a wide range, but he is best known for the classical researches he carried out on animal fats, published in 1823 (Recherches sur les corps gras d'origine animale). These enabled him to elucidate the true nature of soap; he was also able to discover the composition of stearin, a white substance found in the solid parts of most animal and vegetable fats, and olein, the liquid part of any fat, and to isolate stearic and oleic acids, the names of which he invented. This work led to important improvements in the processes of candle-manufacture. Chevreul was a determined enemy of charlatanism in every form, and a complete sceptic as to the "scientific" psychical research or spiritualism which had begun in his time. His research on the "magic pendulum", Dowsing rods and table-turning is revolutionary. In an open letter to André-Marie Ampère in 1833, and his 1854 paper "De la baguette", Chevreul explains how human muscular reactions, totally involuntary and subconscious, are responsible for seemingly magical movements. In the end, Chevreul discovered that once a person holding divining rods/magic pendulum became aware of the brain's reaction, the movements stopped and could not be willingly reproduced. His was one of the earliest explanations of the ideomotor effect.
== Taxonomy == This species was originally noted and named in 1753 by Carl Linnaeus as Agaricus campestris. It was placed in the genus Psalliota by Lucien Quelet in 1872. Some variants have been isolated over the years, a few of which now have species status, for example, Agaricus bernardii Quel. (1878), Agaricus bisporus (J.E. Lange) Imbach (1946), Agaricus bitorquis (Quel.) Sacc. (1887), Agaricus cappellianus Hlavacek (1987), and Agaricus silvicola (Vittad.) Peck (1872). Some were so similar they did not warrant even varietal status, while others have retained it. Agaricus campestris var. equestris (F.H.Moller) Pilat (1951) is still valid. A. campestris var. isabellinus (F.H.Moller) Pilat (1951), and A. campestris var. radicatus, are possibly still valid too. The Latin specific epithet campestris means "of the fields". Common names given to the fungus include "meadow mushroom", "pink bottom", and "field mushroom". An analysis of ribosomal DNA of a limited number of members of the genus showed A. campestris to be an early offshoot in the genus and sister taxon to A. cupreobrunneus.
Providing a plane of separation, or disconnection, between solid tissues so that movement can occur with minimum bending of solid components. If this separation is lost, as in a 'frozen shoulder', the joint cannot move. Providing a packing that can change shape in whatever way is needed to allow the bearing surfaces to move on each other. Controlling the volume of fluid in the cavity so that it is just enough to allow the solid components to move over each other freely. This volume is normally so small that the joint is under slight suction.
Sources: en.wikipedia.org
The lyophilized powder is generally stored at -20 °C or lower, desiccated, and protected from light. Solutions are often aliquoted to avoid repeated freeze-thaw cycles. Specific stability data may vary by formulation and purity.
Mass spectrometry is commonly used to confirm molecular mass, while RP-HPLC estimates purity. These methods can be combined with amino acid analysis or NMR for further structural confirmation. A certificate of analysis alone does not guarantee independent verification.
Legality depends on the country and the intended use. In many places it is not approved as a drug and may be regulated as a research chemical. Buyers should check local laws and institutional policies before obtaining it.
Published human trials are lacking. Most evidence comes from laboratory and animal studies. Therefore, human benefits and risks are not established.